Jefferies European Healthcare Analysts holds a conference call with management to discuss latest trends for key growth drivers such as older adult RSV vaccine Arexvy, shingles vaccine Shingrix and Zejula for ovarian cancer on September 18 at 10 am.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GSK:
- GSK says FDA approves Ojjaara for treatment of myelofibrosis
- DiaMedica appoints Ambarish Shah, Ph.D. as Chief Technology Officer
- GSK momelotinib submission for myelofibrosis accepted for review by Japan’s MHLW
- Tonix Pharmaceuticals plans to meet potential increased demand for Tosymra
- GSK says sJNDA for Nucala accepted for review by Japanese regulator